Literature DB >> 15927445

Preventing neural tube defects in Europe: a missed opportunity.

Araceli Busby1, Lenore Abramsky, Helen Dolk, Ben Armstrong, Marie-Claude Addor, Goran Anneren, Nicola Armstrong, Andre Baguette, Ingeborg Barisic, Andrea Berghold, Sebastiano Bianca, Paula Braz, Elisa Calzolari, Marianne Christiansen, Guido Cocchi, Anne Kjersti Daltveit, Hermien De Walle, Grace Edwards, Miriam Gatt, Blanca Gener, Yves Gillerot, Romana Gjergja, Janine Goujard, Martin Haeusler, Anna Latos-Bielenska, Robert McDonnell, Amanda Neville, Birgitta Olars, Isabel Portillo, Annukka Ritvanen, Elizabeth Robert-Gnansia, Christine Rösch, Gioacchino Scarano, Volker Steinbicker.   

Abstract

Each year, more than 4500 pregnancies in the European Union are affected by neural tube defects (NTD). Unambiguous evidence of the effectiveness of periconceptional folic acid in preventing the majority of neural tube defects has been available since 1991. We report on trends in the total prevalence of neural tube defects up to 2002, in the context of a survey in 18 European countries of periconceptional folic acid supplementation (PFAS) policies and their implementation. EUROCAT is a network of population-based registries in Europe collaborating in the epidemiological surveillance of congenital anomalies. Representatives from 18 participating countries provided information about policy, health education campaigns and surveys of PFAS uptake. The yearly total prevalence of neural tube defects including livebirths, stillbirths and terminations of pregnancy was calculated from 1980 to 2002 for 34 registries, with UK and Ireland estimated separately from the rest of Europe. A meta-analysis of changes in NTD total prevalence between 1989-1991 and 2000-2002 according to PFAS policy was undertaken for 24 registries. By 2005, 13 countries had a government recommendation that women planning a pregnancy should take 0.4mg folic acid supplement daily, accompanied in 7 countries by government-led health education initiatives. In the UK and Ireland, countries with PFAS policy, there was a 30% decline in NTD total prevalence (95% CI 16-42%) but it was difficult to distinguish this from the pre-existing strong decline. In other European countries with PFAS policy, there was virtually no decline in NTD total prevalence whether a policy was in place by 1999 (2%, 95% CI 28% reduction to 32% increase) or not (8%, 95% CI 26% reduction to 16% increase). The potential for preventing NTDs by periconceptional folic acid supplementation is still far from being fulfilled in Europe. Only a public health policy including folic acid fortification of staple foods is likely to result in large-scale prevention of NTDs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927445     DOI: 10.1016/j.reprotox.2005.03.009

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  28 in total

1.  Polymorphism 677C → T MTHFR gene in Mexican mothers of children with complex congenital heart disease.

Authors:  Norma A Balderrábano-Saucedo; Rocio Sánchez-Urbina; José A Sierra-Ramírez; Normand García-Hernández; Adriana Sánchez-Boiso; Miguel Klunder-Klunder; Diego Arenas-Aranda; Gabriela Bravo-Hernández; Penelope Noriega-Zapata; Alfredo Vizcaíno-Alarcón
Journal:  Pediatr Cardiol       Date:  2012-06-04       Impact factor: 1.655

2.  Folic acid supplements and risk of facial clefts: national population based case-control study.

Authors:  Allen J Wilcox; Rolv Terje Lie; Kari Solvoll; Jack Taylor; D Robert McConnaughey; Frank Abyholm; Hallvard Vindenes; Stein Emil Vollset; Christian A Drevon
Journal:  BMJ       Date:  2007-01-26

3.  Folate of pregnant women after a nationwide folic acid supplementation in China.

Authors:  Xuejuan Zhang; Jufen Liu; Yongsheng Jin; Shuang Yang; Zhijiao Song; Lei Jin; Linlin Wang; Aiguo Ren
Journal:  Matern Child Nutr       Date:  2019-05-23       Impact factor: 3.092

4.  Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study.

Authors:  Patrizia De Marco; Elisa Merello; Maria Grazia Calevo; Samantha Mascelli; Daniela Pastorino; Lucia Crocetti; Pierangela De Biasio; Gianluca Piatelli; Armando Cama; Valeria Capra
Journal:  Childs Nerv Syst       Date:  2011-01-05       Impact factor: 1.475

5.  Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects.

Authors:  F Pangilinan; A Mitchell; J VanderMeer; A M Molloy; J Troendle; M Conley; P N Kirke; M Sutton; J M Sequeira; E V Quadros; J M Scott; J L Mills; L C Brody
Journal:  J Med Genet       Date:  2010-06-24       Impact factor: 6.318

Review 6.  The mandatory fortification of staple foods with folic acid: a current controversy in Germany.

Authors:  Wolfgang Herrmann; Rima Obeid
Journal:  Dtsch Arztebl Int       Date:  2011-04-15       Impact factor: 5.594

7.  MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis.

Authors:  Jinyu Zheng; Xiaocheng Lu; Hao Liu; Penglai Zhao; Kai Li; Lixin Li
Journal:  Neurol Sci       Date:  2014-12-13       Impact factor: 3.307

Review 8.  Developmental origins of health and disease: environmental exposures.

Authors:  James M Swanson; Sonja Entringer; Claudia Buss; Pathik D Wadhwa
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

9.  Imaging the course of a hypoplastic cerebellum in a spina bifida newborn.

Authors:  Annick Kronenburg; Kuo Sen Han; Rob Gooskens; Giuseppe Esposito; Douglas Cochrane; Peter Woerdeman
Journal:  Childs Nerv Syst       Date:  2013-05-19       Impact factor: 1.475

Review 10.  Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks.

Authors:  Andrew E Czeizel; Zoltán Bártfai; Ferenc Bánhidy
Journal:  Ther Adv Drug Saf       Date:  2011-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.